JulieSharplessMD

Diabetes, Lipid Metabolism, Pituitary Disorders & Neuroendocrinology

Associate Professor, Director of UNC Multidisciplinary Pituitary Adenoma Program

Dr. Sharpless is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
101 Manning Dr
Chapel Hill, NC 27514
Phone+1 919-966-4996

Fax+1 919-843-5515

Massachusetts General HospitalFellowship, Endocrinology, Diabetes, and Metabolism, 1996 - 1998
Massachusetts General HospitalResidency, Endocrinology, Diabetes, and Metabolism, 1993 - 1995
Yale School of MedicineClass of 1992

PubMed

147 citations
Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.
J. Bradley Layton, Dongmei Li, Christoph R. Meier, Julie L. Sharpless, Til Stürmer
The Journal of Clinical Endocrinology and Metabolism. 2014-01-06
28 citations
Comparison of multiple methods for identification of hyperprolactinemia in the presence of macroprolactin.
Christopher R. McCudden, Julie L. Sharpless, David G. Grenache
Clinica Chimica Acta; International Journal of Clinical Chemistry. 2010-02-02
65 citations
Comparative Safety of Testosterone Dosage Forms
J. Bradley Layton, Christoph R. Meier, Julie L. Sharpless, Til Stürmer, Susan S. Jick
JAMA Internal Medicine. 2015-07-01

Sharpless Sworn in as Director of the National Cancer InstituteOctober 19th, 2017